MedTrace Logo

Online Learning Portal on Under Five Pneumonia

NCT04495361 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2024-06-12

No results posted yet for this study

Summary

Despite the availability of standard pneumonia management guidelines and multiple global efforts, pneumonia continues to be the leading killer of children under five, accounting to around 17% of the total under five deaths globally. In Pakistan, pneumonia contributes to 16% of under five mortality in the country having a well-defined yet poorly functional healthcare system.

Although, there are standard set of guidelines for management of pneumonia patients however, the management practices of this illness are variable across the country. This could be attributed to non-availability of work ready graduates which in turn is due to variations of teaching methods across various institutions. Although the medical students across these institutions do get exposed to clinical cases in the final year however, this exposure is also variable. If this clinical experience is coupled with an adjunct capacity building mode using an online platform. there is a possibility that students could be trained in a better way.

Conditions

Interventions

OTHER

E-learning portal

An online learning portal for the identification and management of pneumonia in under five children

Sponsors & Collaborators

  • Maternal, Neonatal and Child Health Research Network

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Dr Tabish Hazir, MBBS, FRCPCH · Maternal, Neonatal and Child Health Research Network

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-12-01
Completion
2020-12-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04495361 on ClinicalTrials.gov